Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5193_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
65 Мб
Скачать
468
A. A. Jonsson and M. E. Halkos

Outcomes

Robotic intracardiac surgery can be performed with excellent safety and efcacy. Our technique has a less than 1% mortality and stroke rate, and at 6years freedom from recurrent 2+ or greater MR was 85%, with only 3.9% of patients requiring reoperation for mitral repair failure [16]. Other experienced centers have published similar results [17, 18]. The safety of robotic mitral surgery is comparable to other approaches including thoracotomy and sternotomy and is associated with shorter length of stay and lower hospital readmissions [1].

Robotic Aortic Valve Replacement

One of the newest applications in robotic cardiac surgery is robotic aortic valve replacement. Although not yet widely performed, initial results from this technique are encouraging with less than 1% mortality and stroke rates [19]. Aortic valve replacement can be performed in conjunction with mitral valve procedures, abla­tions, and transaortic septal myectomy (Fig.32.7).
Fig. 32.7 Mitral valve before and after repair. This patient had posterior leaet prolapse which was treated with neocords and annuloplasty
32 Robotic-Assisted Cardiac Surgery
469

Conclusion

As demand grows for less invasive procedures, we must ensure that we can meet this demand without compromising short- or long-term patient outcomes. Robotic technology is a crucial tool for allowing surgeons to perform gold standard inter­ventions through smaller incisions with minimal morbidity. Despite the slow early adoption in cardiac surgery, robotic cardiac surgical procedures are now routinely performed in many centers across North America and around the world.

References

1. Mori M, Parsons N, Krane M, Guy TS, Grossi EA, Dearani JA, Habib RH, Badhwar V, Geirsson A.Robotic mitral valve repair for degenerative mitral regurgitation. Ann Thorac Surg. 2024;117(1):96–104.
2. Whellan DJ, McCarey MM, Taylor BS, etal. Trends in robotic-assisted coronary artery bypass grafts: a study of the society of thoracic surgeons adult cardiac surgery database, 2006 to 2012. Ann Thorac Surg. 2016;102:140–6.
3. Jonsson A, Binongo J, Patel P, Wang Y, Garner V, Mitchell-Cooks D, Halkos ME.Mastering the learning curve for robotic-assisted coronary artery bypass surgery. Ann Thorac Surg. 2023;115(5):1118–25.
4. Edwards J, Binongo J, Mullin B, Wei J, Ghelani K, Kumarasamy M, Hanson P, Duggan M, Shoffstall J, Halkos M.Intensive care unit bypass for robotic-assisted single-vessel coronary artery bypass grafting. Ann Thorac Surg. 2023;115:511.
5. Mohr FW, Falk V, Diegeler A, Walther T, Gummert JF, Bucerius J, et al. Computer­enhanced “robotic” cardiac surgery: experience in 148 patients. J Thorac Cardiovasc Surg. 2001;121(5):842–53.
6. Argenziano M, Katz M, Bonatti J, Srivastava S, Murphy D, Poirier R, etal. Results of the prospective multicenter trial of robotically assisted totally endoscopic coronary artery bypass grafting. Ann Thorac Surg. 2006;81(5):1666–75.
7. Bonaros N, Schachner T, Lehr E, Koer M, Wiedemann D, Hong P, etal. Five hundred cases of robotic totally endoscopic coronary artery bypass grafting: predictors of success and safety. Ann Thorac Surg. 2013;95(3):803–12.
8. Bonatti J, Schachner T, Bonaros N, Öhlinger A, Danzmayr M, Jonetzko P, etal. Technical challenges in totally endoscopic robotic coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2006;131(1):146–53.
9. Bonaros N, Schachner T, Wiedemann D, Oehlinger A, Ruetzler E, Feuchtner G, etal. Quality of life improvement after robotically assisted coronary artery bypass grafting. Cardiology. 2009;114(1):59–66.
10. Harskamp RE, Williams JB, Halkos ME, Lopes RD, Tijssen JGP, Ferguson TB, et al. Meta- analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease. J Thorac Cardiovasc Surg. 2014;148(5):1837–42.
11. Kayatta MO, Halkos ME, Puskas JD.Hybrid coronary revascularization for the treatment of multivessel coronary artery disease. Ann Cardiothorac Surg. 2018;7(4):500–5.
12. Halkos ME, Vassiliades TA, Douglas JS, Morris DC, Rab ST, Liberman HA, etal. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2011;92(5):1695–701.
13. Gao C, Yang M, Wu Y, Wang G, Xiao C, Liu H, etal. Hybrid coronary revascularization by endoscopic robotic coronary artery bypass grafting on beating heart and stent placement. Ann Thorac Surg. 2009;87(3):737–41.
14. Murphy DA, Jonsson AA, Halkos ME.Endoscopic robotic mitral valve surgery in patients with previous sternotomy cardiac surgery. Innovations (Phila). 2022;17(4):297–303. 14
470
15. Murphy DA, Moss E, Miller J, Halkos ME.Repeat robotic endoscopic mitral valve operation: a safe and effective strategy. Ann Thorac Surg. 2018;105(6):1704–9.
16. Murphy DA, Moss E, Binongo J, Miller JS, Macheers SK, Sarin EL, Herzog AM, Thourani VH, Guyton RA, Halkos ME.The expanding role of endoscopic robotics in mitral valve sur­gery: 1,257 consecutive procedures. Ann Thorac Surg. 2015;100(5):1675–81.
17. Ramzy D, Trento A, Cheng W, De Robertis MA, Mirocha J, Ruzza A, Kass RM.Three hun­dred robotic-assisted mitral valve repairs: the Cedars-Sinai experience. J Thorac Cardiovasc Surg. 2014;147(1):228–35.
18. Mihaljevic T, Jarrett CM, Gillinov AM, Williams SJ, DeVilliers PA, Stewart WJ, Svensson LG, Sabik JF 3rd, Blackstone EH.Robotic repair of posterior mitral valve prolapse versus con­ventional approaches: potential realized. J Thorac Cardiovasc Surg. 2011;141(1):72–80. e1–4
19. Badhwar V, Pereda D, Khaliel FH, Poffo R, Darehzereshki A, Mehaffey JH, Yan TD, Melnitchouk S, Geirsson A, Arghami A, Navia JL, Raikar GV, Weber AC, Ramzy D, Černý Š, Vojáček J, Smith RL, Bonatti J, Thourani VH, Wei LM.Outcomes following initial multicenter experience with robotic aortic valve replacement: dening a path forward. J Thorac Cardiovasc Surg. 2024;S0022-5223(24):00078–3.
A. A. Jonsson and M. E. Halkos

Mediastinal Procedures

33
BrittneyWilliams andManuSancheti

Introduction

Historically, resection of mediastinal pathology has required invasive surgical approaches via sternotomy, posterolateral thoracotomy, or anterolateral thoracot­omy with or without transverse sternotomy (clamshell). Since the early 1990s, min­imally invasive techniques have transformed mediastinal surgery, allowing for smaller incisions, shorter hospital stays, improved postoperative pain, and compa­rable oncologic outcomes when applicable [1, 2]. Video-assisted thoracoscopic sur­gery (VATS) has been utilized for various mediastinal pathologies including thymectomy for myasthenia gravis, thymoma and thymic carcinoma, germ cell tumors, neurogenic tumors, mediastinal cysts, lymphoma, and ectopic parathyroid and thyroid tissue [3].
Given the limited working space within the mediastinum and close proximity to great vessels, robotic-assisted thoracoscopic surgery has allowed for several advan­tages to navigation and dissection of the mediastinum. The benets of robotics as compared to VATS include articulating instruments, three-dimensional visualiza­tion, scaling down of operative movements, and lack of tremor. Disadvantages include lack of tactile sensation, higher costs, initial learning curve, and lack of standardized approaches to robotic mediastinal procedures.
In this chapter, approaches to robotic mediastinal procedures are detailed, spe­cically categorized into three anatomical sections, the anterior, middle, and poste­rior mediastinum. The mediastinum is bounded laterally by the pleura, superiorly by the thoracic inlet, posteriorly by the thoracic spine, and inferiorly by the dia­phragm. Within these boundaries, the mediastinum is further divided into anterior, middle, and posterior compartments. The anterior mediastinum is located between
B. Williams · M. Sancheti (*) Emory University School of Medicine, Atlanta, GA, USA e-mail: manu.suraj.sancheti@emory.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025 S. Samreen et al. (eds.), The SAGES Manual of Robotic Surgery,
https://doi.org/10.1007/978-3-031-86927-3_33
471
472
the sternum and anterior border of the pericardium. The middle mediastinum lies between the anterior and posterior borders of the pericardium. The posterior medi­astinum is the space between the posterior border of the pericardium and the ante­rior longitudinal ligament of the thoracic spine.
B. Williams and M. Sancheti
Preoperative Evaluation andPatient Selection
Preoperative evaluation for robotic mediastinal procedures is generally the same as open cases with several caveats. A thorough history and physical examination should be performed, particularly including history of prior chest surgeries that may indicate higher risk of conversion to an open procedure. Computed tomography (CT) with intravenous (IV) contrast is essential in evaluation of mediastinal lesions and their proximity to the great vessels and other important mediastinal structures as well as for planning port placement. Additional cross-sectional imaging can be useful in some circumstances, such as magnetic resonance imaging (MRI) in evalu­ating for local invasion and positron emission tomography (PET) for assessment of metastatic disease in malignant mediastinal pathologies. Histopathologic conrma­tion via percutaneous, transbronchial, or endoscopic biopsy can also be useful in cases where clinical, laboratory, or radiographic ndings are inconclusive. Pulmonary function testing is recommended as poor pulmonary function may not allow for single-lung ventilation.
Patient selection plays a key role in successful completion of a robotic approach to mediastinal surgery as certain patient factors and past medical and surgery his­tory can be prohibitive. In terms of patient factors, body habitus may preclude mini­mally invasive access to the anterior mediastinum. History of pleural space infections, malignancy, or prior instrumentation can result in chest wall adhesions that may require conversion to an open procedure. Inability to safely discern the appropriate anatomy for dissection is another common reason for conversion, which can be related to decreased working space from inability to tolerate carbon dioxide insufation or single-lung ventilation. Other reasons for conversion to open include close proximity or involvement of vital mediastinal structures. The latter causes for conversion are largely avoided with appropriate preoperative workup.
General Port Placement andRobotic Positioning Considerations
Port placement and robotic positioning is a key aspect of successful mediastinal robotic operations. Positioning will vary depending on use of either the da Vinci Si or Xi surgical system (Intuitive Surgical, Sunnyvale, CA). In this chapter, the described approach will be based on use of the da Vinci Xi surgical system. In gen­eral, the camera port should be placed 10–20cm away from the target anatomy.
33 Mediastinal Procedures
473
Ports should be placed 6–10cm apart (ideally 8cm) to decrease conict between the robotic arms. Preoperative imaging studies are key in determining appropriate port placement especially for masses in the middle mediastinum and posterior mediastinum where variability in tumor location is more common. Patient cart posi­tioning will vary based on operating room layout.
Approach toAnterior Mediastinal Pathology
Anterior mediastinal pathologies for which robotic surgery has been utilized include thymus for myasthenia gravis, thymoma, lymphoma/lymph node excisional biopsy, germ cell tumors, and ectopic parathyroid and thyroid tissue. Specic preoperative consideration may be necessary for anterior mediastinal pathology. Myasthenia gra­vis patients have increased risks for general anesthesia requiring preoperative prep­aration with pyridostigmine, intravenous immune globulin (IVIG), or plasmapheresis. IVIG should be given 2weeks prior to planned resection. Potential anesthetic­related issues include resistance to depolarizing paralytic agents, cholinergic crisis for neuromuscular blocking reversal agents, increased risks of aspiration, increased risks of respiratory failure, and continued requirements for intubation and ventilator use postoperatively. If the differential for the anterior mediastinal mass includes thymoma, screening for symptoms related to myasthenia gravis should be com­pleted to direct further preoperative laboratory investigation to avoid potential anesthesia- related complications.
Indications forRobotic Anterior Mediastinal Mass Resection
Cross-sectional imaging, CT and/or MRI, is required to evaluate the association of an anterior mediastinal mass with its surrounding mediastinal structures to deter­mine resectability of the lesion. In the case of a thymoma, complete resection is required for adequate treatment due to risk of recurrence. Therefore, Masaoka stage I tumors, enclosed within the thymic capsule, have been deemed acceptable for minimally invasive techniques [4]. Some data does suggest that minimally invasive resections of Masaoka stage I–III thymomas have equivalent rates of margin of positivity and similar 5-year survival, but longer-term follow-up is needed given the indolent nature of thymoma [5]. Robotic resections for anterior mediastinal germ cell tumors are indicated for mature teratomas and dermoid cysts. Seminomatous and non-seminomatous tumors are treated primarily with radiation and chemother­apy, respectively. If a mass persists after initial treatment, further medical treatment may be indicated or surgical resection if tumor markers AFP and beta-HCG are negative and remaining mass does not involve mediastinal structures. Excision of enlarged anterior mediastinal lymph nodes may also be appropriate for diagnosis of lymphoma or staging for other malignancies.
474
bc
B. Williams and M. Sancheti
Fig. 33.1 Computed tomography scan for an anterior mediastinal mass. Red arrows point to the anterior mediastinal mass. (a) Axial, (b) coronal, (c) sagittal. Anterior mediastinal mass does not appear to involve surrounding mediastinal structures and appears to be encapsulated by thymus and surrounding thymic fat
a
Anterior Mediastinal Mass Example Case Scenario
A 67-year-old man undergoing workup for unintentional weight loss is found to have an incidental anterior mediastinal mass surrounded by thymus and thymic fat on CT (Fig. 33.1). He has no symptoms concerning for myasthenia gravis. Differential diagnosis included thymic hyperplasia, thymic carcinoma, thymoma, and lymphoma. The patient elected to undergo resection of the anterior mediasti­nal mass.
Surgical equipment used:
da Vinci Xi robotic system da Vinci 0-degree camera Long bipolar grasper EndoWrist® Clip applier—small and large EndoWrist® Cadiere forceps Vessel sealer extend 8mm instrument cannula × 3 (including one Optiview) 12mm AirSeal trocar 5mm Optiview trocar (optional) 5mm 30-degree thoracoscope Endo Catch bag Kittner roll gauze sponges
33 Mediastinal Procedures
475
Patient Positioning andPort Placement
Anterior mediastinal masses may be approached from either the right or the left side of the chest. In our example, a right-sided approach was used. A double-lumen endotracheal tube is inserted. The patient is placed in supine position with a jelly­roll, beanbag, or rolled sheet along the posterior midclavicular line to elevate the operative side. The arms are tucked with the arm on the operative side allowed to sit slightly below the OR table to allow more space for the robotic arms. The patient’s entire chest is prepped and draped to allow access to the contralateral side if needed.
The right pleural space is accessed with an 8mm Optiview trocar along the ante­rior axillary line at the midpoint of the sternum (typically the fth intercostal space). The layers of the chest wall should be visualized during insertion to allow for safe entry into the pleural space (Fig.33.2). After insufation to 8mmHg, two additional 8mm ports are inserted under direct visualization along the anterior axillary line, port #1in the third intercostal space and port #2in the seventh intercostal space (Fig.33.3). Port #1 can sometimes require bariatric length to clear the underlying arm. Finally, a 12mm AirSeal is inserted in the midclavicular line as low as possible just above the diaphragm.
The robot is then driven into operative eld from the contralateral side and per­pendicular to the patient centered on the camera trocar. The ports are then secured into the robotic arms with the remote center of the three robotic ports just within the intercostal muscle of the chest wall. The 8mm 0-degree da Vinci camera is passed into the center camera port. Under direct visualization, the Cadiere forceps are placed into the port #1 followed by the long bipolar grasper (or robotic vessel sealer) into port #2.
Anterior Mediastinal Mass Excision Operative Steps
The phrenic nerve is rst identied along the pericardium, as this nerve must be preserved and denes the posterior border of the dissection. If unable to be visual­ized at any point in the operation, a 5mm port can be placed on the contralateral side to allow the assistant to aid in visualization with a 30-degree thoracoscope. We use the long bipolar grasper to initiate the dissection of the mediastinal pleura just anterior to the phrenic nerve running along the superior vena cava (Fig.33.4). The Kittner roll gauzes are inserted into the thoracic cavity through the access port to assist with absorbing minor bleeding and assist with retraction. The dissection of the mediastinal pleura is extended caudad to the inferior pole of the thymic tissue above the diaphragm denoting the right-sided inferior border of dissection. The mediastinal pleural incision is then extended cephalad to the innominate vein (Fig.33.5). Care must be taken as the dissection nears the innominate vein, as clips may be necessary to divide vein branches to the thymus. Thymic tissue underneath the innominate is dissected free. The thymic tissues are dissected off the pericar­dium posteriorly to the mediastinal pleura on the left side which is incised at the same level as on the right side. The anterior dissection is started just medial to the
476
B. Williams and M. Sancheti
Fig. 33.2 Thoracic cavity entry using 5mm Optiview trocar with 5mm thoracoscope. (a) Subcutaneous fat layer, (b) muscle layer, (c) lung parenchyma visualized
a
b
c
internal mammary vessels (Fig.33.6). Arterial branches may need to be clipped and divided supplying the thymus. The right-sided superior pole of the thymus is then dissected free using caudad and posterior traction (Fig.33.7). A clip is usually nec­essary at the superior aspect of the pole to control bleeding. The dissection is then carried over to the left superior pole, which is similarly dissected away from the inferior neck (Fig. 33.8). The dissection is then carried over to the mediastinal pleura on the anterior aspect of the dissection along the sternum. The left pleural
33 Mediastinal Procedures
477
AAL
MAL
PAL
Camera
1
st
1
nd
2
rd
3
th
4
th
5
th
6
Assistant
th
7
2
th
th
8
9
Fig. 33.3 Port placement for robotic anterior mediastinal mass resection. AAL (anterior axillary line), MAL (midaxillary line), PAL (posterior axillary line). Port sites are labeled blue for camera port, yellow for robotic port 1, green for robotic port 2
Fig. 33.4 Initial dissection plane for anterior mediastinal mass resection. The phrenic nerve and SVC (superior vena cava) are identied. The cephalad and caudad directions are denoted for orientation
space is entered anteriorly taking care not to injury the left internal mammary artery. The thymus is retracted over to the right side and the left lobe of the thymus is dis­sected free (Fig.33.9). An Endo Catch bag is inserted through the 12mm AirSeal port and the specimen is removed from the pleural cavity. The robotic instruments are then retracted and the robot disengaged from the ports. A 24 Fr chest tube is